ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

ASCO Guideline On Breast Cancer Risk Reduction Updated

May 29, 2009

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

Major Changes Being Considered By NCI For FCRA

April 14, 1978

Study Suggests Surveillance Colonoscopies Overperformed

August 27, 2004

Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare

April 5, 2013